betamethasone/calcipotriene (Enstilar)
Jump to navigation
Jump to search
Indications
Dosage
- apply QD to affected areas for up to 4 weeks. Patients should
- stop when control is achieved
- maximum dose 60 g every 4 days (15 g/day)
alcohol-free foam in a pressurized spray for application to large areas of plaque psoriasis
Adverse effects
- skin irritation & pruritus at sites of application
- folliculitis,
- skin hypopigmentation
- hypercalcemia
- urticaria
- exacerbation of psoriasis
More general terms
Components
- betamethasone dipropionate; betamethasone valerate (Celestone, Soluspan, Betasone)
- calcipotriene; calcipotriol (Dovonex, Dovobet)
References
- ↑ Brooks M FDA OKs Topical Drug Combo (Enstilar) for Plaque Psoriasis. http://www.medscape.com/viewarticle/852952